Compare Bundamedik Tbk (BMHS) vs Sarimelati Kencana Tbk. (PZZA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Sarimelati Kencana Tbk. — how do they compare? Bundamedik Tbk trades at Rp188 (market cap 1.63T, 380K 24h volume), while Sarimelati Kencana Tbk. trades at Rp181 (market cap 549.98B, 257.8K 24h volume). The key difference: Bundamedik Tbk is far larger — about 3× Sarimelati Kencana Tbk.'s market cap, and Bundamedik Tbk is more actively traded (380K versus 257.8K). Which is the better fit depends on your goals.
| BMHS | PZZA | |
|---|---|---|
Market Cap | 1.63T | 549.98B |
Volume | 380K | 257.8K |
Lot | 3.8K | 2.58K |
Turnover | 71.29M | 46.92M |
Average Price | 187.59 | 182 |
Value | 71.29M | 46.92M |
Indicative Equilibrium Price | 188 | — |
Indicative Equilibrium Volume | 105 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Sarimelati Kencana Tbk.
PT Sarimelati Kencana Tbk. (the Company) was established based on Notarial Deed No. 132 dated December 16, 1987 of Lieke Lianadevi Tukgali, S.H.
Read more on PZZA →
